Autologous stem-cell transplantation for multiple myeloma: a Brazilian institution experience in 15 years of follow-up

Autologous stem-cell transplantation for multiple myeloma: a Brazilian institution experience in 15 years of follow-up

Objective: To determine the 5-year post-transplant survival ofpatients with multiple myeloma. Methods: A retrospective study inpatients diagnosed with multiple myeloma submitted to autologousbone marrow transplantation at a Brazilian institution, during theperiod of 1993 to 2007. Results: Seventy-th...

Full description

Bibliographic Details
Main Authors:	Juliana Todaro, Ana Rita de Araújo Burgos Manhani, José Mauro Kutner, Andreza Alice Feitosa Ribeiro, Morgani Rodrigues, Fabio Rodrigues Kerbauy, Jairo Nascimento Sobrinho, Eurípedes Ferreira, Nelson Hamerschlak
Format:	Article
Language:	English
Published:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2011-06-01
Series:	Einstein (São Paulo)
Subjects:	Multiple myeloma Transplantation autologous Bone marrow transplantation Survivorship (Publich Health)
Online Access:	http://apps.einstein.br/revista/arquivos/PDF/1845-Einstein_v9n2_119-123.pdf

Similar Items

AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: IS IT STILL THE RIGHT CHOICE?
by: Patrizia Tosi
Published: (2014-07-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-11-01)

Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
by: Bergantim Rui, et al.
Published: (2012-11-01)

Axoval neuropathy as initial manifestation of primary amyloidosis: report of a case submitted to bone marrow transplantation
by: Orlando G. Povoas Barsottini, et al.
Published: (2004-09-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

Survival and response deepening after autologous transplantation in patients with multiple myeloma in Chile
by: María Carolina Guerra, et al.
Published: (2022-12-01)

Double Autologous Stem Cell Transplantation in a Case of Non-secretory Multiple Myeloma
by: Lázár Erzsébet, et al.
Published: (2016-12-01)

Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
by: Simone A. Minnie, et al.
Published: (2021-03-01)

Clinical Outcomes of Autologous Hematopoietic Stem Cell Transplant in Multiple Myeloma Patients: A 5-year Experience from a Single Centre in North India
by: Nitin Sood, et al.
Published: (2023-04-01)

Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
by: Lakshmi Yarlagadda, et al.
Published: (2021-08-01)

A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation
by: Wancheng Guo, et al.
Published: (2024-03-01)

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
by: Malkan Umit Yavuz, et al.
Published: (2021-01-01)

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study
by: Anna Waszczuk-Gajda, et al.
Published: (2022-06-01)

The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysis
by: Swaroop Revannasiddaiah, et al.
Published: (2022-05-01)

Pretransplant Determinants of Outcome in Patients with Myeloma Undergoing Autologous Transplantation in Lower Resource Settings
by: Chandran Nair
Published: (2021-06-01)

Enterococcus raffinosus infection with atypical hemolytic uremic syndrome in a multiple myeloma patient after autologous stem cell transplant
by: Pankaj Mathur, et al.
Published: (2017-09-01)

Outcomes of autologous transplantation for multiple myeloma according to different induction regimens
by: Edvan de Queiroz Crusoe, et al.
Published: (2014-01-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

The correlation between T regulatory cells and autologous peripheral blood stem cell transplantation in multiple myeloma
by: Ayşe Pınar Erçetin, et al.
Published: (2011-06-01)

The correlation between T regulatory cells and autologous peripheral blood stem cell transplantation in multiple myeloma
by: Ayşe Pınar Erçetin, et al.
Published: (2011-05-01)

Autologous hematopoietic transplantation following COVID‐19 infection
by: Marthilde Brzycki, et al.
Published: (2021-03-01)

Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization
by: Alzbeta Zavrelova, et al.
Published: (2019-06-01)

Tandem autologous hematopoietic stem cell transplantation for patients with multiple myeloma: a systematic review and meta-analysis
by: Hongtao Li, et al.
Published: (2024-12-01)

Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03)
by: Zoe van de Wyngaert, et al.
Published: (2023-02-01)

Impact of melphalan day -1 vs day -2 on outcomes after autologous stem cell transplant for multiple myeloma
by: Aimee Merino, et al.
Published: (2024-03-01)

Circulating monocyte subsets in multiple myeloma patients receiving autologous stem cell transplantation – a study of the preconditioning status and the course until posttransplant reconstitution for a consecutive group of patients
by: Ida Marie Rundgren, et al.
Published: (2019-11-01)

Risk Factors for Catheter-Related Thrombosis in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
by: Anna Hoppe, et al.
Published: (2021-09-01)

Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?
by: Sonia Morè, et al.
Published: (2022-02-01)

The Evolution of Intracardiac Hemodynamics Post Autologous Stem Cell Transplant in a Case of Multiple Myeloma Associated with Severe Tricuspid and Mitral Valve Insufficiency
by: Tudor Cezara-Iuliana, et al.
Published: (2017-12-01)

Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era
by: Huixing Zhou, et al.
Published: (2023-04-01)

Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy
by: Charlotte F. M. Hughes, et al.
Published: (2024-03-01)

Mobilization potential of patients with lymphomas and multiple myeloma involved in autologous stem cell transplant
by: Stančev Katarina, et al.
Published: (2020-01-01)

Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
by: Chuanying Geng, et al.
Published: (2022-12-01)

Autologous followed by allogeneic versus tandem-autologous transplantation in high-risk, newly diagnosed multiple myeloma: a systematic review and meta-analysis
by: Min Wei, et al.
Published: (2023-12-01)

Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis
by: Weerapat Owattanapanich, et al.
Published: (2018-11-01)

Changes in Laboratory Indexes for Multiple Myeloma Patients Before and After Autologous Stem Cell Transplant
by: Zhao R, et al.
Published: (2023-12-01)

Daratumumab‐based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia
by: Carmine Liberatore, et al.
Published: (2023-11-01)

Prognostic Impact on Survival of Early Relapse after Autologous Stem Cell Transplantation with Non-cryopreserved Stem Cells for Multiple Myeloma in Real Life: A Single-center Cohort Study from Oran (Algeria)
by: Mohamed Amine Bekadja, et al.
Published: (2022-02-01)

Treatment of multiple myeloma patients with autologous stem cell transplantation — a fresh analysis
by: Malgorzata Wach, et al.
Published: (2011-07-01)